Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Brickell Biotech Inc (BBI)

Brickell Biotech Inc (BBI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,754
  • Shares Outstanding, K 2,874
  • Annual Sales, $ 400 K
  • Annual Income, $ -39,470 K
  • 60-Month Beta 0.02
  • Price/Sales 16.36
  • Price/Cash Flow N/A
  • Price/Book 0.40
Trade BBI with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -13.52
  • Most Recent Earnings $-0.01 on 08/11/22
  • Latest Earnings Date N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/22
See More
  • Average Estimate -1.59
  • Number of Estimates 2
  • High Estimate -1.35
  • Low Estimate -1.82
  • Prior Year -7.21
  • Growth Rate Est. (year over year) +77.95%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.21 +6.33%
on 09/07/22
4.10 -42.68%
on 08/08/22
-1.42 (-37.67%)
since 08/05/22
3-Month
2.21 +6.33%
on 09/07/22
12.60 -81.35%
on 06/29/22
-3.95 (-62.70%)
since 06/07/22
52-Week
2.21 +6.33%
on 09/07/22
37.35 -93.71%
on 09/08/21
-34.55 (-93.63%)
since 09/07/21

Most Recent Stories

More News
Will Brickell (BBI) Report Negative Earnings Next Week? What You Should Know

Brickell (BBI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

BBI : 2.35 (+2.17%)
CCXI : 51.99 (+0.06%)
Ironwood Pharmaceuticals (IRWD) Misses Q2 Earnings and Revenue Estimates

Ironwood (IRWD) delivered earnings and revenue surprises of -32.26% and 2.19%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

IRWD : 7.89 (-2.35%)
BBI : 2.35 (+2.17%)
Brickell Biotech to Participate at William Blair Biotech Focus Conference 2022

BOULDER, Colo., July 06, 2022 (GLOBE NEWSWIRE) -- Brickell Biotech, Inc. (“Brickell” or the “Company”) (Nasdaq: BBI), a clinical-stage pharmaceutical...

BBI : 2.35 (+2.17%)
Brickell Biotech Announces 1-For-45 Reverse Stock Split

Common stock will begin trading on a split-adjusted basis on July 5, 2022...

BBI : 2.35 (+2.17%)
Brickell (BBI) Reports Q1 Loss, Lags Revenue Estimates

Brickell (BBI) delivered earnings and revenue surprises of -33.33% and 52.33%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

BBI : 2.35 (+2.17%)
GANX : 3.06 (-0.33%)
Brickell Biotech Reports First Quarter 2022 Financial Results and Provides Corporate Update

Completed sale of sofpironium bromide to Botanix Pharmaceuticals for up to $9 million in upfront and potential near-term regulatory milestone payments,...

BBI : 2.35 (+2.17%)
Lyra Therapeutics, Inc. (LYRA) Reports Q1 Loss, Tops Revenue Estimates

Lyra Therapeutics, Inc. (LYRA) delivered earnings and revenue surprises of 41.30% and 114.68%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?...

LYRA : 4.83 (-6.58%)
BBI : 2.35 (+2.17%)
Assertio (ASRT) Surpasses Q1 Earnings and Revenue Estimates

Assertio (ASRT) delivered earnings and revenue surprises of 122.22% and 10.50%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

ASRT : 0.8143 (+3.72%)
BBI : 2.35 (+2.17%)
Brickell Biotech to Report First Quarter 2022 Financial Results and Provide a Corporate Update on May 12, 2022

BOULDER, Colo., May 05, 2022 (GLOBE NEWSWIRE) -- Brickell Biotech, Inc. (“Brickell” or the “Company”) (Nasdaq: BBI), a clinical-stage pharmaceutical...

BBI : 2.35 (+2.17%)
Concert Pharmaceuticals (CNCE) Reports Q1 Loss, Misses Revenue Estimates

Concert (CNCE) delivered earnings and revenue surprises of -7.53% and 100%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

CNCE : 8.37 (+0.12%)
BBI : 2.35 (+2.17%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Brickell Biotech, Inc. is a clinical-stage pharmaceutical company. It is focused on developing prescription therapeutics for treatment of skin diseases. The company's pipeline consists of therapeutics for hyperhidrosis, cutaneous T-cell lymphoma, psoriasis, and other prevalent severe skin diseases. ...

See More

Key Turning Points

3rd Resistance Point 2.57
2nd Resistance Point 2.47
1st Resistance Point 2.41
Last Price 2.35
1st Support Level 2.25
2nd Support Level 2.15
3rd Support Level 2.09

See More

52-Week High 37.35
Fibonacci 61.8% 23.93
Fibonacci 50% 19.78
Fibonacci 38.2% 15.63
Last Price 2.35
52-Week Low 2.21

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar